Tag: R&D

IP
IFPMA Policy Principles on COVID-19 Vaccines Initiative
Global Biopharma CEO/Top Executives COVID-19 Media Briefing - 28 May 2020 (Video)
Pharma partners in efforts to give coronavirus vaccine for everyone
IFPMA Statement @EB 142: Global strategy and plan of action on public health, innovation and intellectual property
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
Doing our part: Comprehensive efforts to fight Neglected Tropical Diseases (NTDs)
Doing our part: Innovating to fight Neglected Tropical Diseases
G-FINDER Report 2016: The biopharmaceutical industry confirms its status as a significant funder of neglected disease R&D
The R&D-based biopharmaceutical industry at the forefront of addressing AMR
Zika & Ebola: How global health threats prompt innovation (Visual recording of the panel discussion)
IFPMA 2016 interview series on 'The R&D challenges in tackling Zika virus'
Vaccines innovation
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
Ebola
Economic footprint
Sustainable innovation
IFPMA members' antibacterial compounds pipeline inventory 2015
7 Recommendations for a new economic model to incentivize innovation, meet preservation goals and ensure access to antibiotics
R&D pipeline for malaria
Partners in the global fight against tuberculosis
Tuberculosis today
Doing our part: Efforts of the research-based pharmaceutical industry to fight TB
Pharmaceutical industry and global health
Pharmaceutical industry makes progress in cutting-edge R&D for neglected diseases
Doing our part: Partnerships to boost R&D for unmet medical needs
Doing our part: landmark medicine donations
Doing our part: Comprehensive efforts to fight NTDs
Doing our part: Implementation of capacity-building efforts
Technology transfer: a collaborative approach to improve global health
1 2

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Statement Immunization Incremental Innovation Influenza Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers